A Study of Diroximel Fumarate (DRF) in Adult Participants From the Asia-Pacific Region With Relapsing Forms of Multiple Sclerosis (RMS)

PHASE3CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

November 18, 2021

Primary Completion Date

September 11, 2024

Study Completion Date

September 11, 2024

Conditions
Relapsing Forms of Multiple Sclerosis
Interventions
DRUG

Diroximel fumarate

Administered as specified in the treatment arm

Trial Locations (52)

10050

The Affiliated Hospital of Inner Mongolia Medical University, Hohhot

30012

Shanxi Provincial People's Hospital, Taiyuan

100006

Beijing Hospital, Beijing

100050

Beijing Tiantan Hospital, Capital Medical University, Beijing

110004

Shengjing Hospital of China Medical University, Shengyang

130021

The First Hospital of Jilin University, Changchun

150040

The First Affiliated Hospital of Harbin Medical University, Harbin

150086

The Second Affiliated Hospital of Harbin Medical University, Harbin

200001

Renji Hospital Shanghai Jiaotong University School of Medicine - West Branch, Shanghai

215004

The First Affiliated Hospital of Soochow University, Suzhou

230022

The First Affiliated Hospital of Anhui Medical University, Hefei

300052

Tianjin Medical University Affiliated General Hospital, Tianjin

330006

Jiangxi Provincial People's Hospital, Nanchang

The First Affiliated Hospital of Nanchang University, Nanchang

350001

Fujian Medical University Union Hospital, Fuzhou

410008

Xiangya Hospital, Central South University, Changsha

430030

Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan

510080

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou

510180

Guangzhou First People's Hospital, Guangzhou

510260

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

510515

Nanfang Hospital of Southern Medical University, Guangzhou

510630

The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou

523059

Dongguan People's Hospital, Dongguan

610072

Sichuan Provincial People's Hospital, Chengdu

650032

First Affiliated Hospital of Kunming Medical University, Kunming

710038

Tangdu Hospital, Fourth Military Medical University, Xi'an

730030

Lanzhou University Second Hospital, Lanzhou

750004

General Hospital of Ningxia Medical University, Yinchuan

063003

Tangshan Gongren Hospital, Tangshan

260-8677

Chiba University Hospital, Chiba

276-8524

Tokyo Womens Medical University Yachiyo Medical Center, Yachiyo

791-0295

Ehime University Hospital, Toon-shi

814-0180

Fukuoka University Hospital, Fukuoka

807-8556

Hospital of the University of Occupational and Environmental Health, Kitakyushu-shi

963-8563

Southern Tohoku Medical Clinic, Koriyama-shi

070-8644

NHO Asahikawa Medical Center, Asahikawa-shi

080-0024

Obihiro Kosei Hospital, Obihiro

063-0005

NHO Hokkaido Medical Center, Sapporo

305-8576

University of Tsukuba Hospital, Tsukuba

020-8505

Iwate Medical University Uchimaru Medical Center, Morioka

236-0004

Yokohama City University Hospital, Yokohama

980-8574

Tohoku University Hospital, Sendai

983-8512

Tohoku Medical and Pharmaceutical University Hospital, Sendai

951-8520

Niigata University Medical & Dental Hospital, Niigata

570-8507

Kansai Medical University Medical Center, Moriguchi-shi

350-8550

Saitama Medical Center, Kawagoe-shi

113-8431

Juntendo University Hospital, Bunkyō City

187-8551

National Center of Neurology and Psychiatry, Kodaira-shi

145-0065

Ebara Hospital, Ōta-ku

162-8666

Department of Neurosurgery, Tokyo Women's Medical University, Shinjuku-ku

641-8510

Wakayama Medical University Hospital, Wakayama

755-8505

Yamaguchi University Hospital, Ube-shi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY